Abstract -(Poly)peptides and proteins are widely distributed over living organisms and are involved in all biological processes. In the laboratory several ways to synthesize these compounds have been investigated; most of the methods involve chemical synthesis either in solution or using the solid phase technique. These and other synthetic methods will briefly be outlined and recent trends in the various areas will be discussed. Strategy and tactics of syntheses will be described, as well as the purification procedures. Finally, methods of analysis of (poly)peptides including recent developments will be mentioned.
INTRODUCTION
The name peptide was coined in 1906 by Emil Fischer who used the nomenclature of saccharides on the one hand and the word peptone, i.e. cleavage products of proteins by enzymes, on the other hand to describe the products formed on linking amino acids via amide bends (or peptide bonds) (ref. 1) . In general the word oligopeptides is used up to a chain length of 10 amino acid residues, polypeptides for a length of 10-100 residues and proteins for even larger molecules. Peptides and proteins exhibit the largest structural and functional variation of all classes of biologically active (macro)molecules. They occur in plants, micro-organisms (peptide antibiotics) and animals, already on a very simple level as in the coelenterate Hydra whose head activator (11 amino acid residues) has been well-studied. Amphibian skin has been found to contain a large variety of peptides, unequalled by any other vertebrate or invertebrate tissue (ref. 2) . In man, one can find peptides everywhere, in the central and autonomous nervous system, gastrointestinal tract, atrial tissue, skin, eye etc. Moreover, several peptide hormones have been identified in tumours and mother milk. Peptides and proteins are of prime importance in the regulation and maintenance of all biological processes. Brain peptides, for example, have been found to have effects on homeostatic systems (each system affected by multiple peptides) including the regulation of pain, blood pressure, temperature, thirst, feeding, learning, memory and trophic function (ref. 3) . Neuropeptides play a role in several neurological diseases as well as in the imune system. In the last decade or so, many new peptides have been isolated and characterized, largely with immunochemical methods and facilitated by the improvement of analytical techniques like highperformance liquid chromatography (HPLC), amino acid analysis and fast atom bombardment mass spectrometry (FAB-MS). Analysis of nucleotide sequences encoding for proteins has provided further additions to the ever-growing list of new proteins. In this review I will attempt to describe the state of the art with respect to the synthesis of these interesting compounds. Trends in peptide chemistry, in the purification and in the analysis of peptides will be discussed. 1 . Biosynthesis Nearly all polypeptides and proteins are biosynthesized via the ribosomal pathway; this involves several steps including activation of amino acids by formation of a mixed anhydride with AMP and transfer to specific tRNA's, formation of the mRNA-ribosome--initiator-tRNA complex, binding of the aminoacyl-tRNA, peptide bond formation, translocation and termination (ref. 5 ); it appears significant that the chain is built up from the amino side. After (and even during) the assembly of a linear polypeptide chain , folding into a three-dimensional structure essential for the execution of biological function occurs. It is now known that many small, naturally occurring peptides are obtained by processing of ribosomally synthesized precursor proteins (ref .
3 ) . These precursor proteins may contain several biologically active products (ref . 6 ).
2. Chemical synthesis in solution a. Protecting groups. Formation of a peptide bond requires the activation of the carboxylic acid function of one amino acid residue (see under 2b . ) . In order to obtain a defined product, reactive functions other than those involved in the formation of the peptide bond must, in general, be blocked by protecting groups. These reactive functions also include side-chain functions such as the thiol, guanidino, imidazole, indole and hydroxyl functions. For some groups protection is obligatory, for others it is facultative (imidazole, indole, hydroxyl) depending on the reaction conditions. In the course of several decades a large number (> 130) of protecting groups for the NH2 function have been developed (ref . [7] [8] [9] . They can be classified either on the basis of their nature, e.g. derived from carboxylic acids, urethane groups (derivod from primary, secondary or tertiary alcohols) , alkyl protecting groups or derivatives of sulfur or phosphorus, or on the basis of their removal: acidolysis, proton abstraction, reduction/oxidation, nucleophilic displacement and photolysis (ref. [7] [8] [9] . Since most peptides are fairly stable under acidic conditions , N-protecting groups (not only for NH2, but also for the imidazole and guanidino nitrogens) with graded sensitivity to cleavage by acids of different strengths have played and still play a dominant role in peptide chemistry. Some of these groups can also be removed by catalytic hydrogenation, and these two deblocking methods are used in over 80% of all syntheses (ref . 8 ) . Representatives of the most widely used urethane-derived amino protecting groups are the benzyloxycarbonyl group, which is removable by catalytic hydrogenation and acidolysis, and the tertiary butyloxycarbonyl (Boc) group which is stable towards hydrogenation and cleavable by mild acid (TFA). Of a more recent date is the 9-f luorenylmethyloxycarbonyl (Fmoc) group which is acid-stable but can be removed by mild basic treatment. With the improvement of chromatographic methods and the increase in sensitivity of analytical techniques it became apparent that small amounts of by-products, like dipeptides and alkylated or racemized side-products can be formed upon the introduction of 2 protecting groups via chloroformates (ref. 10) . Recent trends include the search for alternative methods of introduction of, in particular, the urethane-derived protecting groups by using compounds such as five-membered heterocycles (2-benzoxazolethiol, 2-benzothiazolethiol and 2-benzimidazolethiol, ref. Synthesis and analysis of(poly)peptides 333 Side-chain protection. When histidine is the C-terminal amino acid residue, several sidereactions can occur upon activation (formation of cyclic imidazolides, Nim_amidino derivatives and racemization; ref. 8, 9) . Protection of the imidazole function with groups as shown in Table 1 Table 3 . Many modified benzyl groups have been investigated as candidates for more acid sensitive protection, but without real success in this respect. A more promising line of research led to the triphenylmethyl (trityl) group which has found wide application because of the diversity of removal conditions (see Table 3 ; ref. 29) . The acetamidomethyl (Acm) group can also be removed with mercury ions at pH 4 and with iodine with concomitant oxidation to the disulfide (the Trt can be selectively oxidized in the presence of the Acm group), but is completely stable towards acids. Protection of the side-chain hydroxyl groups of serine, threonine and tyrosine is in general not required. However, when applying strong acylating agents and/or large excesses of activating species, protection should take place (e .g. in solid phase syntheses). The use of side-chain unprotected Ser, Thr and Tyr derivatives may sometimes lead to side-reactions that do not occur in the case of "global" protection but on the other hand complete removal of side-chain protecting groups at the end of a synthesis may also pose problems. The current standard method for blocking the OH functions is to convert them into their benzyl or tert.-butyl ethers (for a comprehensive review, see ref. 31).
b. Coupling methods. In order to form a peptide bond, one of the groups involved must be activated. No practical solution for the activation of the a-amino group has been found as yet. Activation of the carboxylic acid group of a monovalent amino acid derivative followed by coupling with the NH2 group of a suitably protected amino acid will give the desired peptide bond. Only some recent activities in these areas will be mentioned here. Azides.
Initially it was assumed that no racemization occurs during this still very popular coupling reaction, but detailed studies later revealed that this is not true. Avoiding even the slightest excess of base is essential in this case. In addition to the classical route via (protected) hydrazides (ref. Table 4 
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HOBt, is a very efficient catalyst of active ester reactions , (ref. 41 42) .
Anhydrides. Symmetrical anhydrides of acylamino acids, which are highly reactive species, have only been used in stepwise synthesis, mainly in solid phase procedures. From an economic point of view (half of the amount is not used) these are not attractive, in contrast to mixed anhydrides. Mixed anhydrides of N-protected amino acids with carbonic acids have been the most popular especially since conditions were described that minimize the risk of racemiza-(ref. 33, 36) . A thorough, successful study of the reduction of urethane formation and racemization, investigating the effect of base and solvent, has been published recently by Benoiton and co-workers (ref. 43); the use of N-methylpiperidine and dichloromethane is recommended for routine use in mixed anhydride couplings. To overcome undesired urethane formation, derivatives of sulfuric acid but especially of phosphorus have been described (ref. 33) . Recently, several studies on the use of acyloxyphosphonium species in amide bond formation have been published (ref. [44] [45] [46] [47] . Carbodiimide method. Despite shortcomings the use of this coupling reagent has become very popular (and is still used exclusively in solid phase peptide synthesis). Some of the shortcomings, notably racemization and rearrangements, can be suppressed by the use of additives, of which HOBt (ref. 41 ) is most often used both in the condensation of fragments (segments) and in stepwise syntheses (ref. 9, 37, 42) : the "DCC-HOBt procedure" is today 's most favoured coupling method. An interesting unconventional coupling method in which amide bond formation occurs intramolecularly and is preceded by a covalent capture step ("amine capture" or more recently, "thiol capture") has been proposed by Kemp (ref. 48 ).
Synthesis and analysis of(poly)peptides 335 C. Racemization. Racemization at the chiral a atom may take place as a result of the activation of the carboxyl group. This can be via azlactone formation, direct abstraction of the a proton or via .-elimination (accelerated by assistance of some side-chains like those of Cys (Bzl) , Asp(OtBu) , Ser(tBu) , Phe , Tyr and His) . Relatively safe is the activation of urethane-protected amino acids, e.g. by active esters, the azide method with acylamino acids including peptides (provided no excess of base is present) and the addition of non-acylating acids as a source of protons , like HOBt , in coupling reactions (e .g . ref. 9, 49, 50 in this respect is the finding that the addition of thioanisole in acidic deprotection reactions not only has a suppressing effect on side-reactions but also a promoting effect on the cleavage reaction ( "push-pull" mechanism) (ref . 19 , 53) . Final deprotection may still remain problematical because of the "individuality of peptides" (dissimilarity of side-chains and in sequence). This was later found to cause some dipeptide formation and racemization. The problem of these two side-reactions could be solved separately, but we have found a simpler solution to both problems simultaneously, namely the use of HOBt at a lower reaction temperature (ref. 
Enzymatic synthesis
Although the reversal of the catalytic action of a hydrolytic enzyme (papain), i.e. the enzyme-catalyzed peptide synthesis, was already known some 50 years ago, the application of enzymes in peptide synthesis has only clearly increased over the past 10-15 years (ref. 64) . This area has gained in interest especially since the enzymatic synthesis of human insulin from porcine insulin. Numerous model compounds have been synthesized using enzymes from different classes, e.g. chymotrypsin, trypsin, thermitase, papain, subtilisin, pepsin, thermolysin and carboxypeptidase Y. The synthesis of biologically active peptides using enzymes in several or all steps has been described, e.g. Leu-and Met-enkephalin, angiotensin II, caerulein, cholecystokinin-octapeptide, dynorphin, and oxytocin; also the be obtained by changing the concentrations of substrates, the nature of the reaction medium and the pH.
Semis ynthesis
One can envisage here two approaches: in the first, one makes use of a naturally occurring protein or peptide to obtain fragments (enzymatically or chemically, e.g. using cyanogen bromide) which are then used in a re-synthesis with other, synthetic, fragments. Several proteins and (poly)peptides like trypsin inhibitors, myoglobin, lysozyme, acyl carrier protein , insulin , B-and a-MSH have been studied in this way (ref . 68 , 69) , but the best example is cytochrome c with 104 amino acid residues. Cleavage with CNBr at the two Met residues (using a special protection of the lysine side-chains) gives rise to 2 or 3 fragments (depending on the conditions) ; reconstitution of the protein using these and completely synthetic fragments has already provided many analogues of cytochrome c for structure-activity relation- 
AIM, STRATEGY AND TACTICS
The aims of the synthesis of peptides can be of a widely different nature: 1. ii(urgent) need of a certain peptide.
2. In addition to a desired peptide, as many fragments as possible should be obtained, in the free form, for biological/pharmacological testing. 3. To investigate the possibilities of scaling up a synthesis: safety and economic aspects are becoming very important. 4. Synthesis on a microgram scale, e.g. with radioactive material. Depending on the aim, the strategy and tactics of the synthesis have to be formulated. The strategy describes the main lines of the route and takes into account structural features like disulfide bridges. It defines whether fragment condensations or stepwise elongation should be employed, when to use a certain type of protecting group and how to prevent the occurrence of insolubility and of racemization. Tactics include performance of the synthesis using minimally or completely protected intermediates, and which protecting groups and methods of activation and coupling are the most appropriate. The final question, which must be envisaged straight from the beginning is: how can the end-product be deprotected? Some examples are given below:
Target molecule
One of the best examples to illustrate strategy and tactics principles is still the total synthesis of human insulin by the Ciba-Geigy group in 1974 (ref. 74). Insulin consists of two chains of 21 and 30 amino acid residues, respectively, connected by 2 disulfide bridges (and one intra-chain S-S bridge in the A-chain). Directed formation of these three disulfide bridges at different stages of the fragment condensation approach was carried out using two Synthesis and analysis of(poly)peptides 337 SH protecting groups, Trt and Acm, differing in sensitivity towards iodine which is used to deprotect and unify two thiol functions. A new, very mild method was developed for the selective removal of the temporary amino protecting groups occurring simultaneously at the two peptide chains (A and B) in one molecule. Following the completion of the synthesis of the protected molecule (Boc-and OtBu functions) , final deprotection was achieved in one step by acidolysis. In spite of the complexity of the molecule, many analogues have been obtained using this elegant synthesis (ref . 
Target molecule and fragments as biological probes
When we at Organon International started the synthesis of the 31 amino acids containing molecule human 6-endorphin some nine years ago it was known on the one hand that in addition to its opiate-like properties this peptide possessed many other activities, and that on the other hand enzymatic processing generates naturally occurring fragments with diminished opiate activity. Our strategy consisted of the synthesis of fragments that were later coupled to obtain longer peptides and finally 8h_endorphin itself (a so-called "pyramidal" approach: several people working simultaneously on different fragments in the beginning, only one at the end (ref. 81,82). The choice of segmentation was guided by two kinds of arguments. We wanted to obtain as many of the naturally occurring fragments as possible (e.g. fragments 1-5, 1-9, 1-16 i.e. a-endorphin and 1-17 i.e. -endorphin), but then there were also synthetic considerations; for example, coupling of peptides with a C-terminal prolyl or glycyl residue is to be preferred (racemization-safe). 
PRIFICATION
For the purification of (poly)peptides and proteins one can make use of the following possibilities: crystallization, extraction and chromatography. As (poly)peptides, in contrast to proteins, are difficult to crystallize one usually goes straight to the other techniques. In extraction, use is made of the fact that, in general, the main component and by-products of a synthesis have different distribution coefficients in two non-miscible (mixtures of) salvents. Automation of multiple extraction steps has resulted in the counter current distribution machine in which the upper and lower layer move in opposite directions. Much mare applied in practice is the so-called Craig machine, where in the multiplicative distribution, the lower phase retains its position while the upper phase is mobile (ref. 96) on a small scale using analytical columns or on multi-rrg scale using semipreparative columns. Recently, large commercial HPLC instruments (Whatman, Jobin Yvon) have been developed and these will certainly find their way to producers of large amounts of (poly)peptides and proteins.
METHODS OF ANALYSIS
After purification the peptide has to be analyzed. The purity criteria depend on the aim of the synthesis. For a reference compound criteria can be applied that differ from those necessary for clinical release. In such a first, limited, analysis, thin layer chromatography (in several solvent systems and using different detection methods), and often also electrophoresis is carried out followed by reversed phase HPLC (RP-HPLC), which has become a more or less standard analytical technique in most laboratories. Amino acid analysis has to be performed in order to check f or the correct composition; simultaneously the peptide content is obtained, the remainder being water and, in general, acid. That such an amino acid analysis is not superf luau , especially not in solid phase peptide synthesis, can be illustrated by several reports (e.g. ref.
78-80). Our own research group also routinely makes isotachopherograms of our peptide preparations. Analytical capillary isotachophoresis has been shown to be a rapid qualitative and quantitative method for the simultaneous determination of anions (or cations) in peptide preparations (ref. [97] [98] [99] The drawbacks of the use of these reagents (no reaction takes place with proline and hydroxyproline using o-phthalaldehyde, limited stability, formation of multiple derivatives and interfering peaks, the use of a fluorimeter) are not present with the pre-column derivatization procedure using phenylisothiocyanate (PITC) to give phenylthiocarbamyl (PTC) amino acids which can be separated by RP-HPLC and UV detected. Based on this principle a dedicated apparatus was introduced (Pico.Tag Workstation of Waters) in which gasphase acid hydrolysis of the peptide takes place followed by PlC-amino acid formation (ref. 107).
We have recently performed a systematic study of the chromatographic parameters stationary and mobile phase, gradient profile, pH, flow rate and column temperature which has resulted in an HPLC system in which 23 PTC-amino acids are distinctly separated (see Fig. 3 
